CHANGES IN HYDROGEN INDEX AND BLOOD ELECTROLYTES DURING RECOVERY PERIOD AFTER BLOOD LOSS WITH FOLLOWING ADMINISTRATION OF MAGNETITE NANOPARTICLES

Magnetite nanoparticles are one of the extensively investigated and implemented into medical practice. They are known as having significant therapeutic potential in providing rapid recovery of hematological parameters after acute blood loss. Since the pathogenesis of acute blood loss, except of anaemia, includes other components (hypoxia, hypovolemia, acidosis), it is important to know how magnetite nanoparticles affect the parameters of these processes. The aim of this study was to investigate the effect of magnetite nanoparticles on changes in hydrogen index (pH) and blood electrolytes induced by acute blood loss. Materials and methods. The experiment was performed on 47 white male rats. Blood loss (25% of circulating blood) was simulated by puncture of the heart under the ether anesthesia. The nanoparticles’ solution (5-8 nm) was administered intraperitoneally immediately after the blood loss in a dose of 6.75 mg Fe/kg in a volume of at least 1 ml. In 3, 24 and 72 hours, and in 5 day interval, the blood pH and content of HCO3–, Na+, K+ and Ca2+ were checked. The data obtained were processed using one-way variance analysis ANOVA (Statistica for Windows 8.0). Results and discussion. It is shown that magnetite nanoparticles elevated the pH level in 3 hours, reduced in 24 hours and did not affect it in 72 hours and 5 days as compared to the control pathology. The administration of magnetite nanoparticles after 3 hours, 24 hours and 5 days resulted in increase in Na+ content compared to that in blood loss. An increase in the content of K+ took place after 24 hours as compared to the control pathology. Magnetite nanoparticles contributed to the normalization of Ca2+ after 72 hours. The content of HCO3– in all terms of observations ranged within normal limits, except for that in blood loss with magnetite nanoparticles introduced after 24 hours caused the increase of HCO3–in 1.2 times compared to the control pathology. Conclusion. Magnetite nanoparticles, administered to manage the acute blood loss syndrome, are able to modify the acid-base balance and electrolyte content in the blood for 5 days of recovery period that largely depends on the ability of non-iron to accelerate erythropoiesis and thus to restrain other components in the pathogenesis.